Teladoc Health Q3'26 Earnings Conference Call - TELADOC HEALTH INC

Financial Performance:

• Consolidated revenue for Q3 2026 was $605 million, a 3.4% year-over-year decline, landing near the upper end of the guidance range.
• Consolidated adjusted EBITDA reached $79 million, up 13.5% year-over-year, exceeding the high end of guidance; adjusted EBITDA margin improved 200 basis points to 13.1%.
• Integrated Care revenue was $398 million (+2.3% YoY), driven by double-digit international growth and 15% YoY growth in chronic care enrollment; adjusted EBITDA margin expanded 180 bps to 18.8%.
• BetterHelp revenue was $207 million (-12.8% YoY); insurance revenue hit $32 million (exceeding expectations), while cash pay declined due to strategic reductions in marketing spend.
• BetterHelp adjusted EBITDA was $4 million (2.2% margin), with gross margin pressure offset by a 27% YoY reduction in advertising spend.
• Free cash flow was $76 million in Q3, bringing YTD free cash flow to $85 million; ending cash and equivalents stood at $850 million.
• Net debt to trailing adjusted EBITDA decreased 0.5x to 1.0x year-over-year.
• Credit loss per share improved to $0.15 from $0.28 in the prior year.

Guidance and Future Outlook:

• Full-year 2026 consolidated revenue guidance raised to $2.39B–$2.44B (midpoint +$13M); adjusted EBITDA raised to $277M–$303M (midpoint +$3M).
• 2026 adjusted EBITDA margin guidance set at 11.4%–12.5% (approx. 90 bps expansion vs. 2025); free cash flow narrowed to $135M–$165M.
• Integrated Care 2026 revenue growth guidance maintained at 1.1%–2.1%; adjusted EBITDA margin raised to 16%–16.6%.
• BetterHelp 2026 revenue expected to decline 12.9%–16.1%; insurance revenue guidance raised to $99M–$105M.
• Full-year 2026 net loss per share narrowed to $0.75–$0.95.
• Q4 2026 revenue guidance: $569M–$615M; adjusted EBITDA: $74M–$100M.
• Long-term outlook for 2027 includes a target annualized insurance run rate of at least $200M for BetterHelp, with sequential quarterly growth expected.
• Management expects 2027 advertising spend to decline 20%–30% YoY, negatively impacting non-insurance revenue but supporting margin durability.

Business Segments and Product Lines:

• Teladoc One: A comprehensive, outcome-based care model launched with initial pilot partners in July; broader market availability expected in 2027. Leverages AI-driven "Pulse Intelligence" and multidisciplinary teams to address holistic care needs beyond condition-specific silos.
• Hybrid Care: Expanded in the U.S. via the recent acquisition of Teledyne Health, enabling delivery of virtual clinical services within physical hospital settings to address workforce and capacity challenges.
• BetterHelp Insurance Pivot: Strategic shift toward an in-network model; insurance revenue now represents 36% of acquired U.S. users (up 8 bps QoQ). Therapist network expanded by 3,000 in Q3, totaling over 11,000 credentialed providers.
• Technology: New AI-powered capabilities added to Solo platform for contact-free vital sign measurement and ambient clinical documentation to reduce administrative burden.
• Digital Experience: Enhancements to the Teladoc Health app and removal of legacy platforms to broaden consumer reach.

Market and Competitive Landscape:

• Macro environment characterized by health plans adjusting to regulatory changes and rising medical costs; employers seeking solutions that reduce fragmentation and demonstrate ROI.
• Hybrid care models, previously successful internationally, are gaining traction in U.S. hospitals due to workforce shortages and the need for rural/underserved access.
• Mental health market dynamics shifting as insurance capacity expands, reducing the historical necessity of cash-pay models for patients unable to access networks.
• Teladoc One addresses market demand for holistic, accountable care models rather than fragmented point solutions.

Risks and Challenges:

• Cash Pay Pressure: Continued headwinds in BetterHelp's cash pay segment due to consumer affordability challenges and a strategic reduction in advertising spend.
• Insurance Scaling: Risks associated with expanding provider capacity, credentialing speed, and ensuring therapist engagement across diverse markets and payers.
• Selling Season Uncertainty: Macroeconomic factors and health plan budget cycles could impact 2027 booking timelines.
• Debt Maturity: $1 billion in convertible notes maturing in June 2027 require refinancing or repayment; management plans a two-phase approach involving potential early repurchase.
• Seasonality: Q4 typically faces pressure from reduced session utilization and holiday advertising dynamics.

Management Commentary and Tone:

• Tone: Management expressed cautious optimism, highlighting "solid execution" and progress on strategic priorities despite revenue declines.
• Leadership Change: Welcome of new CFO Mike Grasher, who emphasized operational excellence and capital structure strengthening.
• Strategic Confidence: Management is confident in the pivot to insurance for BetterHelp as a more durable long-term model and in the differentiation offered by Teladoc One and hybrid care.
• Investment Stance: Committed to measured incremental investments in Q4 and 2027 to support growth initiatives, funded by strong Q3 adjusted EBITDA performance.

Analyst Questions and Answers:

• Therapist Capacity: Confirmed accelerating credentialing (3,000 therapists in Q3) with planned improvements in compensation models and platform efficiency to drive active participation.
• Cash Pay vs. Insurance: Clarified that while Q3 cash pay was better than expected, the strategic pullback in marketing spend will lead to further declines; insurance growth is the primary long-term driver.
• Teladoc One Revenue: Anticipated to contribute meaningfully to 2027 results, with full commercialization and client conversions expected to ramp through 2028.
• Hybrid Care Definition: Distinguished from previous technology-only sales in the U.S.; the acquisition of Teledyne Health enables the delivery of services within physical settings, mirroring successful international hybrid models.
• Marketing Differentiation: Shift from national, direct-to-consumer campaigns to localized, state-specific insurance-focused marketing to align capacity with demand.
• Internal Referrals: Discussed potential synergies where Integrated Care identifies mental health needs for warm handoffs to BetterHelp, though execution focus remains on scaling the independent insurance model.
• Pricing: Insurance reimbursement rates per session are expected to remain stable, varying slightly by market and payer mix.

Other Key Points:

• BetterHelp achieved an annualized insurance run rate of over $140M based on 27,000 weekly insurance sessions.
• 36% of acquired U.S. users in Q3 came from insurance channels, up 8 percentage points from Q2.
• Management intends to address the 2027 convertible note maturity using a combination of cash and traditional debt financing, aiming for a significantly lower gross debt position post-maturity.
• Full 2027 guidance will be provided during the Q4 earnings call, but 2027 directional targets for insurance ($200M+ run rate) and marketing spend (-20-30%) were provided early.